免疫介导炎症性疾病患者中人乳头瘤病毒诱发癌症的风险:一项全国匹配队列研究
INTRODUCTION: Women with immune-mediated inflammatory diseases (IMIDs) are at an increased risk of human papillomavirus (HPV)-related cervical cancer. Our study aimed to assess the risk of HPV-induced cervical, vaginal, vulvar, anal and penile cancer in patients with IMIDs.…
要点
- IMID患者HPV诱发癌症或重度异型增生风险约为匹配对照的2倍(年龄校正HR 1.99)。
- 女性、SLE、年龄低于65岁和慢性肾脏病是IMID人群中HPV相关癌症/重度异型增生的危险因素。
- 除阴茎癌外,IMID患者所有类型HPV诱发癌症风险均升高,尤其宫颈、外阴、阴道和肛门部位。
核心结论
- IMID患者发生HPV相关癌症或重度异型增生的可能性几乎为匹配对照的两倍,尤其在宫颈、外阴、阴道和肛门部位。
研究设计与样本
- 法国全国匹配队列研究,使用2016至2023年全国医院医疗信息数据库,比较IMID患者与匹配对照。
- 纳入分析的IMID包括系统性红斑狼疮(SLE)、干燥综合征、系统性硬化症、混合性结缔组织病和类风湿关节炎。
主要发现
- IMID患者发生HPV诱发癌症或重度异型增生的年龄校正HR为1.99(95%CI 1.80至2.20),对照为匹配对照。
- 除阴茎癌外,IMID患者所有类型HPV诱发癌症风险均升高。
- 多变量竞争风险分析中,IMID人群HPV诱发癌症/重度异型增生的危险因素包括女性(HR 5.88,95%CI 4.01至8.61)。
- 危险因素还包括SLE(HR 2.08,95%CI 1.70至2.55)、年龄低于65岁(HR 2.09,95%CI 1.70至2.57)和慢性肾脏病(HR 1.44,95%CI 1.18至1.77)。
临床怎么用
- 对IMID患者,尤其女性、SLE、年龄低于65岁或合并慢性肾脏病者,应关注HPV相关癌症和重度异型增生的筛查与监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Women with immune-mediated inflammatory diseases (IMIDs) are at an increased risk of human papillomavirus (HPV)-related cervical cancer. Our study aimed to assess the risk of HPV-induced cervical, vaginal, vulvar, anal and penile cancer in patients with IMIDs. METHODS: We conducted a nationwide matched cohort study comparing patients with IMIDs with a control group using the French nationwide hospital medical information database between 2016 and 2023. The following IMIDs were considered: systemic lupus erythematosus (SLE), Sjögren's syndrome, systemic sclerosis, mixed connective tissue disease and rheumatoid arthritis. The primary outcome was the occurrence of HPV-induced cancer or severe dysplasia. RESULTS: A total of 122 316 patients with IMIDs and 316 047 matched controls were analysed over an 8-year study period, with a mean follow-up of 4.11 (2.47) years. IMIDs were associated with an increased risk of HPV-induced cancer or severe dysplasia (age-adjusted HR 1.99 (95% CI 1.80 to 2.20)) in all patients with IMIDs compared with matched controls. An increased risk was observed in patients with IMIDs for all types of HPV-induced cancer except penile cancer. In the multivariable competing risk analysis, the risk factors for HPV-induced cancer/severe dysplasia in the IMIDs population were female (HR: 5.88 (95% CI 4.01 to 8.61)), SLE (HR: 2.08 (95% CI 1.70 to 2.55)), age under 65 years (HR: 2.09 (95% CI 1.70 to 2.57)) and chronic kidney disease (HR: 1.44 (95% CI 1.18 to 1.77)). CONCLUSION: Patients with IMIDs are almost two times as likely to develop HPV-associated cancer or severe dysplasia, particularly at cervical, vulvar, vaginal and anal sites, compared with matched controls.
引用
- Gros C, Goulenok T, Timsit JF, et al. Risk of cancer induced by human papillomavirus in patients with immune-mediated inflammatory diseases: a nationwide matched cohort study. RMD Open. 2026. PMID: 42457219. doi:10.1136/rmdopen-2026-006927
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。